Release Date: 23/02/11 09:06 Summary: Response to ASX Price and Volume Query Price Sensitive: Yes Download Document 64.53KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%